Roth/MKM Assumes Bioceres Crop Solutions (BIOX) at Buy

Roth/MKM analyst Scott Fortune assumes coverage on Bioceres Crop Solutions (NASDAQ: BIOX) with a Buy rating and a price target of $15.00.

The analyst comments "We are resuming coverage of BIOX with a Buy rating and a $15 PT. BIOX is well positioned with its comprehensive biological crop protection and nutrition portfolio and proprietary HB4 drought-resistant seed platform to address secular sustainability trends to reduce conventional inputs. We expect a continuation of mid-teens organic growth and expanding AEBITDA margins to 25%, driven by ramping HB4 acreage and ongoing penetration into the large Brazilian agriculture market. Additional biological regulatory approvals, scale, and geographic expansion will drive market share and higher margins."

For an analyst ratings summary and ratings history on Bioceres Crop Solutions click here. For more ratings news on Bioceres Crop Solutions click here.

Shares of Bioceres Crop Solutions closed at $11.13 yesterday.

You May Also Be Interested In